Liraglutide ups risk for gallbladder, biliary tract events

(HealthDay)—There is an increased risk for gallbladder- or biliary tract-related events among patients with type 2 diabetes taking liraglutide versus placebo, according to a study published online Aug. 9 in Diabetes Care. Michael A. Nauck, M.D., from St. Josef-Hospital in Bochum, Germany, and colleagues randomly assigned 9,340 patients with type Continue Reading

Modified drug combination may reduce risk of recurrence for some breast cancer patients

Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high Continue Reading

Type 2 diabetes risk up with inflammatory bowel disease

(HealthDay)—Patients with inflammatory bowel disease (IBD) have increased risk of type 2 diabetes, according to a study published online Aug. 5 in Clinical Gastroenterology and Hepatology. Tine Jess, M.D., from the Bispebjerg and Frederiksberg Hospital in Copenhagen, Denmark, and colleagues conducted a nationwide population-based cohort study involving 6,028,844 persons in Continue Reading

Malaria control success in Africa at risk from spread of multi-drug resistance

In the first continent-wide genomic study of malaria parasites in Africa, scientists have uncovered the genetic features of Plasmodium falciparum parasites that inhabit different regions of the continent, including the genetic factors that confer resistance to anti-malarial drugs. This sheds new light on the way that drug resistance is emerging Continue Reading

Vape at your own risk, expert says

On the heels of media reports of dozens of injuries suffered by people who vape, the University of Virginia’s Blue Ridge Poison Center issued a statement Wednesday cautioning that vaping is a suspected cause of lung injury. We caught up with the poison center’s medical director, Dr. Christopher Holstege, to Continue Reading

Leading experts in high-risk pregnancies issue report on reproductive health services

Safe reproductive health services, including contraception and abortion, can be lifesaving for some women. However, accessing these services can be a challenge for many women in the United States, particularly low-income women of color. Restrictive state legislation, disparities in access to trained providers, and a lack of evidence-based, standardized guidelines Continue Reading

Changes associated with autism risk may be detected as early as the second trimester

Researchers at University of Utah Health have identified a link between autism and steroid hormone changes detected in the mother’s blood. These changes, which suggest increased estrogen activity, can be seen early in the second trimester. The pilot study, published in the Journal of Autism and Developmental Disorders, opens a Continue Reading

GP model used to calculate risk of cardiovascular disease could be misleading patients

A new study by researchers at The University of Manchester suggests that the current statistical model used by GPs to predict a patient’s risk of developing cardiovascular disease (CVD) could be producing misleading results. The research was published in the open-access journal Scientific Reports. “Clinicians often use risk scores to Continue Reading